Skip to main content

Peer Review reports

From: Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations

Original Submission
6 Feb 2017 Submitted Original manuscript
21 Apr 2017 Author responded Author comments - Robert Hollis
15 Apr 2017 Reviewed Reviewer Report - Christina Annunziata
22 Feb 2017 Reviewed Reviewer Report - Elise Kohn
Resubmission - Version 2
21 Apr 2017 Submitted Manuscript version 2
23 Oct 2017 Author responded Author comments - Robert Hollis
Resubmission - Version 3
23 Oct 2017 Submitted Manuscript version 3
Publishing
22 Dec 2017 Editorially accepted
3 Jan 2018 Article published 10.1186/s12885-017-3981-2

You can find further information about peer review here.

Back to article page